Study confirms defect in sweat gland function as disease biomarker for XLHED
Links shared publicly online about this topic.
- 740total visits
Study confirms defect in sweat gland function as disease biomarker for XLHED
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced key findings of a study exploring novel approaches to the assessment of sweat function in males with XLHED. Affected individuals lack a normal sweat response, placing them at life-long risk for clinically-significant hyperthermia.
View full resource at news-medical.net
Tags: Genetic, Gland, Disease and Condition, Pharma, Biotech, News, disease, Genetics
Most Recently Shared on November 9, 2010 at 7:55 am By:
Genetics News: Study confirms defect in sweat gland function as disease biomarker for XLHED: Edimer Pharmaceutic... http://bit.ly/ayTNrT
Advertisement
